Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 66.55 INR 2.18% Market Closed
Market Cap: 2B INR

Operating Margin

5.6%
Current
Improving
by 18%
vs 3-y average of -12.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.6%
=
Operating Income
₹60.4m
/
Revenue
₹1.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.6%
=
Operating Income
₹60.4m
/
Revenue
₹1.1B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Brooks Laboratories Ltd
NSE:BROOKS
1.9B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.7B USD
Loading...
US
Danaher Corp
NYSE:DHR
170.5B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.8B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in India
Percentile
42nd
Based on 5 437 companies
42nd percentile
5.6%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Brooks Laboratories Ltd
Glance View

Brooks Laboratories Ltd. is a research and development driven pharmaceutical manufacturing company. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2011-09-02. The firm operates through the Pharmaceuticals segment. The company manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. The company offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. The firm has two manufacturing plants, which are located at Baddi in Himachal Pradesh and Vadodara in Gujarat. The firm manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.

BROOKS Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.6%
=
Operating Income
₹60.4m
/
Revenue
₹1.1B
What is Brooks Laboratories Ltd's current Operating Margin?

The current Operating Margin for Brooks Laboratories Ltd is 5.6%, which is above its 3-year median of -12.4%.

How has Operating Margin changed over time?

Over the last 3 years, Brooks Laboratories Ltd’s Operating Margin has increased from -36.3% to 5.6%. During this period, it reached a low of -52.8% on Mar 31, 2023 and a high of 5.6% on Jul 30, 2025.

Back to Top